Beauty Brands Target ‘Ozempic Face’ Market Amid Obesity Drug Surge, ETRetail
Swiss skincare firm Galderma, Brazilian cosmetics group Natura and beauty giant L’Oreal are testing treatments for consumers worried…
Pfizer (PFE) Heads To ESMO With 45 Oncology Abstracts And Fresh Cancer Data
Pfizer (NYSE:PFE) is set to feature data from 45 oncology research abstracts at the upcoming ESMO Congress. The…
Top 3 AI Healthcare Stocks With Revenue Growth Up To 24%
Rising global concern around AI safety at the Trump Xi summit puts a spotlight on where artificial intelligence…
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Healthcare investors often weigh the dividends and pipelines of industry titans. Are you looking for the steady cash…
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
The pharmaceutical industry is shifting as legacy blockbusters lose patent protection. Investors must choose between AbbVie Inc (NYSE:ABBV)…
As global drug giants grow cautious, can Chinese biotech keep cashing in on out-licensing?
Record-breaking cross-border deals helped make some formerly loss-making Chinese biotech companies profitable in the first half of the…
Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?
Quick Read Abbott (ABT) is down 23% year to date with insiders buying near $92; Pfizer (PFE) pairs…
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Quick Read Pfizer’s 7% yield and forward P/E of 8 complement Viatris’s three FDA PDUFA decisions arriving before…
2 Dirt Cheap Healthcare Stocks to Buy in July
Quick Read NVO trades at a forward P/E of 14 and PFE at just 8x, making both the…
This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ Portfolios
Quick Read PFE’s 7.27% yield looks safe on a 53% adjusted payout ratio, but free cash flow fell…
The next goal for weight loss drugs? Fewer injections
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…
Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
Chai Discovery cofounders Josh Meier (left) and Jack Dent Cody Pickens for Forbes L ast June, when AI…